PI statement
The authors confirm that the Principal Investigator for this paper is
Professor Colm Bergin and that he had direct clinical responsibility for
patients. The PI confirms that we have complied with our institution’s
policies concerning research involving human subjects and the  NREC
policies for protection of human subjects.
Keywords:
- Medication Safety
- Clinical Pharmacy
- Adverse Drug Events
- COVID-19
- Hydroxychloroquine
- Azithromycin
Word Count: 2799
Table Count: 8
Figure Count: 2
Running Head:
Clinical Outcomes and ADEs in Covid-19 Patients